碳离子再照射治疗Ⅰ期非小细胞肺癌首程碳离子放疗后复发
本研究回顾性分析29例Ⅰ期非小细胞肺癌首程碳离子放疗后原野内复发患者,再照射中位剂量66.0Gy(RBE)/12次,2年总生存率69.0%、局部控制率66.9%、无进展生存率51.7%,仅1例3级细菌性肺炎且非放射性,认为碳离子再照射是可接受的根治性再治疗。
要点
- 再照射中位剂量66.0Gy(RBE)/12次,2年OS 69.0%、LC 66.9%、PFS 51.7%。
- 除1例3级细菌性肺炎(非放射性)外,无≥2级不良反应。
- 再照射中位皮肤最大剂量53.8Gy(RBE),中位平均肺剂量7.3Gy(RBE)。
核心结论
- 对Ⅰ期非小细胞肺癌首程碳离子放疗后原野内复发,碳离子再照射是可接受的根治性再治疗。
研究设计与样本
- 回顾性分析2007年1月至2014年3月首程碳离子放疗后原野内复发的Ⅰ期非小细胞肺癌患者,共29例符合条件。
- 再照射时中位年龄74岁(范围53-90),再照射开始后中位观察期29个月(范围4-88)。
主要发现
- 再照射后2年总生存率为69.0%(95%CI:50.3-83.0)。
- 再照射后2年局部控制率为66.9%(95%CI:47.5-81.9)。
- 再照射后2年无进展生存率为51.7%(95%CI:34.1-68.9)。
- 中位皮肤最大剂量为53.8Gy(RBE)(范围4.4-103.1),中位平均肺剂量为7.3Gy(RBE)(范围2.6-14.0)。
- 除1例(3.4%)3级细菌性肺炎(非放射性)外,无重于2级的不良反应。
关键数值与推荐
- 首程中位处方剂量为46.0Gy(RBE),再照射中位处方剂量为66.0Gy(RBE)/12次。
临床怎么用
- 对首程碳离子放疗后原野内复发的Ⅰ期非小细胞肺癌,可考虑碳离子再照射作为根治性再治疗选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate carbon-ion radiotherapy (CIRT) for in-field recurrence of stage I non-small cell lung cancer (NSCLC) initially treated with CIRT. MATERIALS AND METHODS: From January 2007 to March 2014, patients initially treated for stage I NSCLC with CIRT and relapsed in-field were candidates. Overall survival (OS) rate, local control (LC) rate, progressive free survival (PFS) rate, dose to the lungs and skin, and adverse effects were analyzed. RESULTS: Twenty-nine patients were eligible. Median age at re-irradiation was 74years (range 53-90). Median observation period from the first day of re-irradiation was 29months (4-88months). Median prescribed dose was 46.0Gy (RBE) as initial treatment and 66.0Gy (RBE) in 12 fractions as re-irradiation. Two-year OS, LC, and PFS rates after re-irradiation were 69.0% (95% CI: 50.3-83.0), 66.9% (95% CI: 47.5-81.9), and 51.7% (95% CI: 34.1-68.9). Median skin maximum dose was 53.8Gy (RBE) (range 4.4-103.1) and median of mean lung dose was 7.3Gy (RBE) (range 2.6-14.0). There were no severer than grade 2 adverse effects except one (3.4%) grade 3 bacterial pneumonia, which was not considered radiation-induced. CONCLUSION: CIRT for stage I NSCLC local recurrence is an acceptable definitive re-treatment.
引用
- Karube M, Yamamoto N, Tsuji H, et al. Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy. Radiother Oncol. 2017. PMID: 28784437. doi:10.1016/j.radonc.2017.07.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。